GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

01

BiliSeq DNA/RNA Next-Generation Sequencing Improves the Diagnosis of Neoplastic Bile Duct Strictures: Gastroenterology | August 2026

Introduction: Distinguishing benign from malignant biliary strictures remains one of the greatest challenges in pancreatobiliary endoscopy. Although ERCP brush cytology and biopsy have excellent specificity, their sensitivity is...

02

Engineered Microbial Lipase: GHE | July 2026

Introduction: Pancreatic enzyme replacement therapy (PERT) is the standard treatment for exocrine pancreatic insufficiency (EPI) but is currently derived exclusively from porcine pancreatic extracts, requiring multiple capsules and...

03

Deep Learning for Automated Pancreatic Cancer Segmentation: NPJ Precision Oncology | July 2026

Introduction: Accurate tumour segmentation is fundamental for precision oncology, enabling objective assessment of tumour burden, treatment response, and radiomics analysis. This study developed and validated an anatomically constrained...

04

When Can We Safely Stop Follow-up IPMN Surveillance: Annals of Surgery | July 2026

Introduction: The widespread detection of intraductal papillary mucinous neoplasms (IPMNs) has substantially increased surveillance programs, although only a small proportion progress to pancreatic cancer. This study evaluated the...

05

Robotic vs Laparoscopic Cholecystectomy: JAMA Surgery | July 2026

Introduction: Robotic cholecystectomy continues to expand worldwide, but its value compared with conventional laparoscopy remains debated. This large study evaluated whether the robotic platform offers meaningful clinical or...

06

MEK Inhibitor–Immunotherapy in Cholangiocarcinoma: Hepatology | July 2026

Introduction: Advanced cholangiocarcinoma (CCA) remains difficult to treat, with limited benefit from current chemotherapy and immunotherapy combinations. This study investigated whether combining a MEK inhibitor (MEKi), anti-PD-L1 therapy,...

07

Ivonescimab Plus Gemcitabine–Cisplatin in Biliary Tract Cancer (BTC): Journal of Hepatology | July 2026

Introduction: Advanced biliary tract cancer (BTC) carries a poor prognosis, with limited improvements in survival despite the addition of immune checkpoint inhibitors to standard gemcitabine–cisplatin chemotherapy. This phase...

08

GLP-1 Receptor Agonists and Gallbladder Disease: UEG Journal | June 2026

Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a cornerstone in the management of type 2 diabetes because of their excellent glycemic, cardiovascular, and weight-loss benefits. However,...

09

Remnant Duct Dilatation Rarely Signals IPMN Recurrence : Ann Surg | Jun 2026

Introduction: Patients undergoing pancreatoduodenectomy for non invasive intraductal papillary mucinous neoplasm (IPMN) require long-term surveillance because of the risk of disease recurrence in the pancreatic remnant. New pancreatic...

10

Post-Pancreatectomy Chyle Leak: Annals of Surgery | June 2026

This study evaluated 1,063 patients undergoing pancreatic surgery; 11% developed conventionally defined chyle leak. Most clinically relevant cases were grade B, while no grade C leaks were reported....

Previous
123456
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer